The United States guidelines for the management of community-acquired pneumonia and their relevance to Australasia

Internal Medicine Journal

Volumn 37, Issue 12, 2007, Pages 789-791

  Waterer, G W ^a   Grayson, M L ^b  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AMPICILLIN; AZITHROMYCIN; CEFEPIME; CEFTAZIDIME; CEFTRIAXONE; CIPROFLOXACIN; CLARITHROMYCIN; DOXYCYCLINE; GENTAMICIN; MACROLIDE; PENICILLIN G; PIPERACILLIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

AUSTRALIA AND NEW ZEALAND; COMMUNITY ACQUIRED PNEUMONIA; EDITORIAL; MEDICAL SOCIETY; PENICILLIN RESISTANCE; PNEUMONIA SEVERITY INDEX; PRACTICE GUIDELINE; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; STREPTOCOCCUS PNEUMONIAE;

ANTI-BACTERIAL AGENTS; AUSTRALIA; CENTERS FOR DISEASE CONTROL AND PREVENTION (U.S.); COMMUNITY-ACQUIRED INFECTIONS; HUMANS; PNEUMONIA; PRACTICE GUIDELINES AS TOPIC; SEVERITY OF ILLNESS INDEX; UNITED STATES;

EID: 36348987667     PISSN: 14440903     EISSN: 14455994     Source Type: Journal    
DOI: 10.1111/j.1445-5994.2007.01548.x     Document Type: Editorial

References (17)

1. Mandell LA, Wunderink RG, Anzueto A, Bartlett JG, Campbell GD, Dean NC et al. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis 2007 44 Suppl. 2 : S27 72.
2. Therapeutic guidelines: Antibiotic, Version 13. Melbourne : Therapeutic Guidelines Limited, 2006.
3. Lim WS, van der Eerden MM, Laing R, Boersma WG, Karalus N, Town GI et al. Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study. Thorax 2003 58 : 377 82.
4. Fine MJ, Auble TE, Yealy DM, Hanusa BH, Weissfeld LA, Singer DE et al. A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med 1997 336 : 243 50.
5. Aujesky D, Auble TE, Yealy DM, Stone RA, Obrosky DS, Meehan TP et al. Prospective comparison of three validated prediction rules for prognosis in community-acquired pneumonia. Am J Med 2005 118 : 384 92.
6. Bartlett JG, Dowell SF, Mandell LA, File TM, Jr., Musher DM, Fine MJ. Practice guidelines for the management of community-acquired pneumonia in adults. Infectious Diseases Society of America. Clin Infect Dis 2000 31 : 347 82.
7. Niederman MS, Mandell LA, Anzueto A, Bass JB, Broughton WA, Campbell GD et al. Guidelines for the management of adults with community-acquired pneumonia. Diagnosis, assessment of severity, antimicrobial therapy, and prevention. Am J Respir Crit Care Med 2001 163 : 1730 1754.
8. Heffelfinger JD, Dowell SF, Jorgensen JH, Klugman KP, Mabry LR, Musher DM et al. Management of community-acquired pneumonia in the era of pneumococcal resistance: a report from the Drug-Resistant Streptococcus pneumoniae Therapeutic Working Group. Arch Intern Med 2000 160 : 1399 408.
9. Roche PW, Krause VL, Bartlett M, Coleman D, Cook H, Davis C et al. Invasive pneumococcal disease in Australia, 2004. Commun Dis Intell 2006 30 : 80 92.
10. Falagas ME, Siempos II, Bliziotis IA, Panos GZ. Impact of initial discordant treatment with beta-lactam antibiotics on clinical outcomes in adults with pneumococcal pneumonia: a systematic review. Mayo Clin Proc 2006 81 : 1567 74.
11. Klugman KP. Clinical impact of antibiotic resistance in respiratory tract infections. Int J Antimicrob Agents 2007 29 Suppl.1 : S6 10.
12. Vergis EN, Indorf A, File TM, Jr., Phillips J, Bates J, Tan J et al. Azithromycin vs cefuroxime plus erythromycin for empirical treatment of community-acquired pneumonia in hospitalized patients: a prospective, randomized, multicenter trial. Arch Intern Med 2000 160 : 1294 1300.
13. British Thoraeic Society. BTS guidelines for the management of community acquired pneumonia in adults. Thorax 2001 56 Suppl. 4 : IV1 64.
14. Dylewski J, Davidson R. Bacteremic pneumococcal pneumonia associated with macrolide failure. Eur J Clin Microbiol Infect Dis 2006 25 : 39 42.
15. Daneman N, McGeer A, Green K, Low DE. Macrolide resistance in bacteremic pneumococcal disease: implications for patient management. Clin Infect Dis 2006 43 : 432 8.
16. Waterer GW. Monotherapy versus combination antimicrobial therapy for pneumococcal pneumonia. Curr Opin Infect Dis 2005 18 : 157 63.
17. Mortensen EM, Restrepo MI, Anzueto A, Pugh J. The impact of empiric antimicrobial therapy with a beta-lactam and fluoroquinolone on mortality for patients hospitalized with severe pneumonia. Crit Care 2005 10 : R8.